Old Web
English
Sign In
Acemap
>
authorDetail
>
Kanako Nakajima
Kanako Nakajima
Tokyo University of Pharmacy and Life Sciences
Endocrinology
Internal medicine
Myasthenia gravis
Prednisolone
Glucocorticoid
4
Papers
90
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Low-dose glucocorticoid therapy complements the pituitary-adrenocortical system and reduces anxiety and insomnia in myasthenia gravis patients.
2012
Clinical Neuropharmacology
Suguru Ito
Masayuki Masuda
Sachiko Tanaka
Miwa Takagi
Chinami Tanaka
Nao Yamada
Kanako Nakajima
Takao Akashi
Toshihiko Hirano
Hiroya Utsumi
Show All
Source
Cite
Save
Citations (3)
Clinical implications of the type 1/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients.
2010
European Journal of Pharmacology
Masayuki Masuda
Sachiko Tanaka
Kanako Nakajima
Nao Yamada
Nobuhiro Ido
Takao Ohtsuka
Masashi Nishida
Toshihiko Hirano
Hiroya Utsumi
Show All
Source
Cite
Save
Citations (10)
Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
2010
Journal of Neuroimmunology
Masayuki Masuda
Moe Matsumoto
Sachiko Tanaka
Kanako Nakajima
Nao Yamada
Nobuhiro Ido
Takao Ohtsuka
Masashi Nishida
Toshihiko Hirano
Hiroya Utsumi
Show All
Source
Cite
Save
Citations (77)
Suppressive potencies of calcineurin inhibitors against the mitogen-induced blastogenesis of peripheral-blood mononuclear cells of myasthenia gravis patients.
2008
Journal of Pharmacy and Pharmacology
Sachiko Tanaka
Kanako Nakajima
Toshihiko Hirano
Kitaro Oka
Toyokazu Saito
Nobuo Wakata
Show All
Source
Cite
Save
Citations (0)
1